Literature DB >> 7931438

Guillain-Barré syndrome: the evolution of therapy.

D R Cornblath, R A Hughes.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7931438     DOI: 10.1007/bf02033360

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

2.  Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  P O Osterman; J Fagius; G Lundemo; P Pihlstedt; R Pirskanen; A Sidén; J Säfwenberg
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

3.  Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

4.  Guillain-Barré syndrome: is there a role for plasmapheresis?

Authors:  A Asbury; R Fisher; G M McKhann; W Mobley; A Server
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

5.  Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.

Authors: 
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

6.  Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group.

Authors: 
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

  6 in total
  2 in total

1.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

Review 2.  Guillian Barré syndrome--recent advances.

Authors:  V V Vedanarayanan; V Chaudhry
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 5.319

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.